from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1299/prfA

LFCtreatmentdescriptionclass of inhibitor

0.659

Amikacinug/mL Amikacintranslation

0.411

Cap5-10ug/mL Capreomycintranslation

1.102

Rox10-50 ug/mL Roxithromycintranslation

0.887

SM2-5 ug/mL Streptomycintranslation

1.721

Tet5-10 ug/mL Tetracyclinetranslation

1.767

Rif0.2-5ug/mL Rifampicintranscription

1.262

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.701

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.527

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.150

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.239

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.604

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.498

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.617

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.412

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-1.114

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.757

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.152

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.272

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.554

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.776

KCN5-20 ug/mL Potassium cyaniderespiration

-0.888

NaN30.2-2 mM Sodium aziderespiration

-1.091

Nigericin50 uM Nigericinrespiration

0.117

TRC10-150 ug/mL Triclosanrespiration

-0.870

TRZ10-25 ug/mL Thioridazinerespiration

1.072

Valinomycin0.5-10 uM Valinomycinrespiration

-0.685

ZnSO42 mM ZnSO4respiration

0.363

menadione6-10 ug/mL Menadionerespiration

-0.598

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.759

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.246

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.928

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.669

NRP_1Non-replicating persistence stage 1dosRassociated

-0.027

Amp0.2mg/mL AmpicillincellWall

-0.462

Cephalexin20-100 ug/mL CephalexincellWall

-0.573

Cerulenin0.32-5 ug/mL CerulenincellWall

1.349

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.503

EMB10-20 ug/mL EthambutolcellWall

-0.611

Eta12-40 ug/mL EthionamidecellWall

-0.758

INH0.2-0.4 ug/mL IsoniazidcellWall

0.219

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.218

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.173

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.618

BZA0.12 mg/mL BenzamidearomaticAmides

0.250

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.579

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.030

H2O24 mM hydrogen peroxideDNAdamaging

0.035

Levo10 ug/mL LevofloxacinDNAdamaging

0.015

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.111

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.721

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.180

UVUV-irradiationDNAdamaging

-0.321

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.518

Antimycin12.5-50 ug/mL Antimycin A?

-0.716

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.671

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.699

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.566

PA8240.2-2 ug/mL PA-824?

-0.635

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.113

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.876

Verapamil50 uM Verapamil?

-0.135

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.657

methoxatin10-20 ug/mL Methoxatin?